Streptococcus pneumoniae

Principles and Practice of Pediatric Infectious Diseases, Fourth Edition

Volumn , Issue , 2012, Pages 721-728.e6

  Ampofo, Krow ^a,b   Byington, Carrie L ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84966781523     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2702-9.00125-2     Document Type: Chapter

References (182)

1. B White (1938) The Biology of Pneumococcus. New York: The Commonwealth Fund
2. World Health Organization (2007) Pneumococcal conjugate vaccine for childhood immunization: WHO position paper. Wkly Epidemiol Rec 82 93-104.
3. KL O’Brien, LJ Wolfson, JP Watt, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374 893-902.
4. HB Konradsen (2005) Validation of serotyping of Streptococcus pneumoniae in Europe. Vaccine 23 1368-1373.
5. J Eskola, T Kilpi, A Palmu, et al. (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 403-409.
6. G Carvalho Mda, ML Tondella, K McCaustland, et al. (2007) Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 45 2460-2466.
7. JC McAvin, PA Reilly, RM Roudabush, et al. (2001) Sensitive and specific method for rapid identification of Streptococcus pneumoniae using real-time fluorescence PCR. J Clin Microbiol 39 3446-3451.
8. CE Corless, M Guiver, R Borrow, et al. (2001) Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39 1553-1558.
9. MD Poulter, JG Deville, JD Cherry, et al. (2005) Real-time fluorescence polymerase chain reaction (PCR) identification of Streptococcus pneumoniae from pleural fluid and tissue. Scand J Infect Dis 37 391-392.
10. ED Carrol, M Guiver, S Nkhoma, et al. (2007) High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J 26 416-422.
11. I Obando, C Munoz-Almagro, LA Arroyo, et al. (2008) Pediatric parapneumonic empyema, Spain. Emerg Infect Dis 14 1390-1397.
12. K Ampofo, A Herbener, AJ Blaschke, et al. (2010) Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J 29 905-909.
13. AJ Blaschke, C Heyrend, CL Byington, et al. (2011) Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 30 289-294.
14. SL Batt, BM Charalambous, TD McHugh, et al. (2005) Novel PCR-restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates. J Clin Microbiol 43 2656-2661.
15. R Pai, RE Gertz and B Beall (2006) Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44 124-131.
16. M Orange and BM Gray (1993) Pneumococcal serotypes causing disease in children in Alabama. Pediatr Infect Dis J 12 244-246.
17. R Prymula, P Peeters, V Chrobok, et al. (2006) Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 740-748.
18. WP Hausdorff, J Bryant, PR Paradiso and GR Siber (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. Part I. Clin Infect Dis 30 100-121.
19. GL Rodgers, A Arguedas, R Cohen and R Dagan (2009) Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 27 3802-3810.
20. A Hoberman, JL Paradise, N Shaikh, et al. (2011) Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila) 50 114-120.
21. N Porat, U Amit, N Givon-Lavi, et al. (2010) Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel. Pediatr Infect Dis J 29 126-130.
22. MC McEllistrem, JM Adams, K Shutt, et al. (2005) Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999–2001. Emerg Infect Dis 11 969-972.
23. CG Whitney, MM Farley, J Hadler, et al. (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 1737-1746.
24. LA Hicks, LH Harrison, B Flannery, et al. (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196 1346-1354.
25. RJ Singleton, TW Hennessy, LR Bulkow, et al. (2007) Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 1784-1792.
26. T Pilishvili, C Lexau, MM Farley, et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201 32-41.
27. OT Avery, CM MacLeod and M McCarty (1995) Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from Pneumococcus type III. 1944. Mol Med 1 344-365.
28. G Gherardi, CG Whitney, RR Facklam and B Beall (2000) Major related sets of antibiotic-resistant pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis 181 216-229.
29. TJ Coffey, MC Enright, M Daniels, et al. (1998) Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol 27 73-83.
30. BM Gray, GM Converse 3rd and HC Dillon Jr (1980) Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 142 923-933.
31. RK Syrjanen, KJ Auranen, TM Leino, et al. (2005) Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage. Pediatr Infect Dis J 24 801-806.
32. T Smith, D Lehmann, J Montgomery, et al. (1993) Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 111 27-39.
33. AB Brueggemann, DT Griffiths, E Meats, et al. (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187 1424-1432.
34. SK Obaro (2001) Protein conjugate vaccines: how much is enough? Trends Microbiol 9 364-365.
35. PE Kim, DM Musher, WP Glezen, et al. (1996) Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 22 100-106.
36. TR Talbot, KA Poehling, TV Hartert, et al. (2005) Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. American. J Med 118 285-291.
37. K Ampofo, J Bender, X Sheng, et al. (2008) Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 122 229-237.
38. SA Madhi and KP Klugman (2004) A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10 811-813.
39. SA Madhi, H Ludewick, L Kuwanda, et al. (2006) Pneumococcal coinfection with human metapneumovirus. J Infect Dis 193 1236-1243.
40. OS Levine, M Farley, LH Harrison, et al. (1999) Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics 103 E28.
41. MB Haddad, CA Porucznik, KE Joyce, et al. (2008) Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996–2002. Ann Epidemiol 18 139-146.
42. F Ghaffar, IR Friedland and GH McCracken Jr (1999) Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J 18 638-646.
43. PC Hill, A Akisanya, K Sankareh, et al. (2006) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 43 673-679.
44. SM Granat, Z Mia, J Ollgren, et al. (2007) Longitudinal study on pneumococcal carriage during the first year of life in Bangladesh. Pediatr Infect Dis J 26 319-324.
45. MH Samore, MK Magill, SC Alder, et al. (2001) High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics 108 856-865.
46. JO Hendley, MA Sande, PM Stewart and JM Gwaltney Jr (1975) Spread of Streptococcus pneumoniae in families. I: Carriage rates and distribution of types. J Infect Dis 132 55-61.
47. JN Dowling, PR Sheehe and HA Feldman (1971) Pharyngeal pneumococcal acquisitions in “normal” families: a longitudinal study. J Infect Dis 124 9-17.
48. BM Gray, ME Turner and HC Dillon Jr (1982) Epidemiologic studies of Streptococcus pneumoniae in infants: the effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 116 692-703.
49. Centers for Disease Control and Prevention (2000) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49(RR-9), 1-35.
50. R Dagan, N Givon-Lavi, O Zamir, et al. (2002) Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185 927-936.
51. RD Balicer, S Zarka, H Levine, et al. (2010) Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination. Vaccine 28 5591-5596.
52. T Cherian, MC Steinhoff, LH Harrison, et al. (1994) A cluster of invasive pneumococcal disease in young children in child care. JAMA 271 695-697.
53. SL Kaplan, EO Mason Jr, WJ Barson, et al. (1998) Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 102 538-545.
54. MD King, CG Whitney, F Parekh and MM Farley (2003) Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis 37 1029-1036.
55. JA Hoffman, EO Mason, GE Schutze, et al. (2003) Streptococcus pneumoniae infections in the neonate. Pediatrics 112 1095-1102.
56. LC McDonald, K Bryant and J Snyder (2003) Peripartum transmission of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol 41 2258-2260.
57. AL Benin, KL O’Brien, JP Watt, et al. (2003) Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. J Infect Dis 188 81-89.
58. B Flannery, S Schrag, NM Bennett, et al. (2004) Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 291 2197-2203.
59. TR Talbot, KA Poehling, TV Hartert, et al. (2004) Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J 23 726-731.
60. KA Poehling, TR Talbot, MR Griffin, et al. (2006) Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 295 1668-1674.
61. American Academy of Pediatrics (2000) Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106 362-366.
62. American Academy of Pediatrics (2009) Pneumococcal infections. LK Pickering, CJ Baker, DW Kimberlin, SS Long,(Eds) Red Book: 2009 Report of the Committee on Infectious Diseases 28th ed Elk Grove Village, IL: American Academy of Pediatrics 524-535.
63. LG Rubin and B Papsin (2010) Cochlear implants in children: surgical site infections and prevention and treatment of acute otitis media and meningitis. Pediatrics 126 381-391.
64. GM Lee and MB Harper (1998) Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 152 624-628.
65. ER Alpern, EA Alessandrini, LM Bell, et al. (2000) Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 106 505-511.
66. ML Stoll and LG Rubin (2004) Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med 158 671-675.
67. RI Haddy, K Perry, CE Chacko, et al. (2005) Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 24 320-323.
68. KL Carstairs, DA Tanen, AS Johnson, et al. (2007) Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. Ann Emerg Med 49 772-777.
69. CL Byington, MH Samore, GJ Stoddard, et al. (2005) Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41 21-29.
70. B Sard, MC Bailey and R Vinci (2006) An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department. Pediatr Emerg Care 22 295-300.
71. LE Nigrovic, N Kuppermann and R Malley (2008) Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med 15 522-528.
72. M Wilkinson, B Bulloch and M Smith (2009) Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. Acad Emerg Med 16 220-225.
73. AF Messina, K Katz-Gaynor, T Barton, et al. (2007) Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 26 461-467.
74. C Munoz-Almagro, I Jordan, A Gene, et al. (2008) Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 46 174-182.
75. SL Kaplan, WJ Barson, PL Lin, et al. (2010) Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 125 429-436.
76. SB Black, HR Shinefield, S Ling, et al. (2002) Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 21 810-815.
77. TQ Tan, EO Mason Jr, ER Wald, et al. (2002) Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110 1-6.
78. CG Grijalva, JP Nuorti, PG Arbogast, et al. (2007) Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369 1179-1186.
79. F Zhou, MH Kyaw, A Shefer, et al. (2007) Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med 161 1162-1168.
80. JC Nelson, M Jackson, O Yu, et al. (2008) Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 26 4947-4954.
81. CL Byington, K Korgenski, J Daly, et al. (2006) Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 25 250-254.
82. ST Li and DJ Tancredi (2010) Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 125 26-33.
83. CG Grijalva, JP Nuorti, Y Zhu and MR Griffin (2010) Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 50 805-813.
84. KM Eastham, R Freeman, AM Kearns, et al. (2004) Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59 522-525.
85. CL Byington, LY Spencer, TA Johnson, et al. (2002) An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 34 434-440.
86. G Eltringham, A Kearns, R Freeman, et al. (2003) Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol. 41 521-522.
87. JM Bender, K Ampofo, K Korgenski, et al. (2008) Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis 46 1346-1352.
88. RF Kornelisse, CM Westerbeek, AB Spoor, et al. (1995) Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 21 1390-1397.
89. B Kirkpatrick, DS Reeves and AP MacGowan (1994) A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults. J Infect 29 171-182.
90. PN Coant, AE Kornberg, LC Duffy, et al. (1992) Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care 8 200-205.
91. CR Rajasingham, BK Bonsu, JI Chapman, et al. (2008) Serious neurologic sequelae in cases of meningitis arising from infection by conjugate vaccine-related and nonvaccine-related serogroups of Streptococcus pneumoniae. Pediatr Infect Dis J 27 771-775.
92. A Pikis, J Kavaliotis, J Tsikoulas, et al. (1996) Long-term sequelae of pneumococcal meningitis in children. Clin Pediatr (Phila) 35 72-78.
93. JW Kutz, LM Simon, SK Chennupati, et al. (2006) Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg 132 941-945.
94. YN Chao, NC Chiu and FY Huang (2008) Clinical features and prognostic factors in childhood pneumococcal meningitis. J Microbiol Immunol Infect 41 48-53.
95. JH Barker, DM Musher, R Silberman, et al. (1999) Genetic relatedness among nontypeable pneumococci implicated in sporadic cases of conjunctivitis. J Clin Microbiol 37 4039-4041.
96. M Martin, JH Turco, ME Zegans, et al. (2003) An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med 348 1112-1121.
97. JM Buck, C Lexau, M Shapiro, et al. (2006) A community outbreak of conjunctivitis caused by nontypeable Streptococcus pneumoniae in Minnesota. Pediatr Infect Dis J 25 906-911.
98. I Brook, PA Foote and JN Hausfeld (2006) Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. J Med Microbiol 55 943-946.
99. DL Burech, K Koranyi, RE Haynes and RN Kramer (1975) Pneumococcal bacteremia associated with gingival lesions in infants. Am J Dis Child 129 1283-1284.
100. AM Yeager (1979) Gingival lesions in infants with pneumococcal bacteremia. Am J Dis Child 133 97.
101. MJ Gorensek, MH Lebel and JD Nelson (1988) Peritonitis in children with nephrotic syndrome. Pediatrics 81 849-856.
102. JS Bradley, SL Kaplan, TQ Tan, et al. (1998) Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics 102 1376-1382.
103. AP Sirotnak, SC Eppes and JD Klein (1996) Tuboovarian abscess and peritonitis caused by Streptococcus pneumoniae serotype 1 in young girls. Clin Infect Dis 22 993-996.
104. LB Givner, EO Mason Jr, TQ Tan, et al. (2004) Pneumococcal endocarditis in children. Clin Infect Dis 38 1273-1278.
105. M Choi and TL Mailman (2004) Pneumococcal endocarditis in infants and children. Pediatr Infect Dis J 23 166-171.
106. Centers for Disease Control and Prevention (1995) Hemorrhage and shock associated with invasive pneumococcal infection in healthy infants and children – New Mexico, 1993–1994. MMWR Morb Mortal Wkly Rep 43 949-952.
107. GR Cabrera, JD Fortenberry, BL Warshaw, et al. (1998) Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection. Pediatrics 101 699-703.
108. J Brandt, C Wong, S Mihm, et al. (2002) Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 110 371-376.
109. JM Bender, K Ampofo, CL Byington, et al. (2010) Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J 29 712-716.
110. JM Guerin and T Hanslik (1995) Creatine kinase levels and bacteremia. Clin Infect Dis 20 715.
111. DJ Isaacman, Y Zhang, EA Reynolds and GD Ehrlich (1998) Accuracy of a polymerase chain reaction-based assay for detection of pneumococcal bacteremia in children. Pediatrics 101 813-816.
112. R Dagan, O Shriker, I Hazan, et al. (1998) Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol 36 669-673.
113. IC Michelow, J Lozano, K Olsen, et al. (2002) Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis 34 E1-11.
114. M Resti, M Moriondo, M Cortimiglia, et al. (2010) Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis 51 1042-1049.
115. J Rello, T Lisboa, M Lujan, et al. (2009) Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136 832-840.
116. I Obando, LA Arroyo, D Sanchez-Tatay, et al. (2006) Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples. Pediatr Infect Dis J 25 962-963.
117. MI Neuman and MB Harper (2003) Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children. Pediatrics 112 1279-1282.
118. S Maxson, MJ Lewno and GE Schutze (1994) Clinical usefulness of cerebrospinal fluid bacterial antigen studies. J Pediatr 125 235-238.
119. SK Saha, GL Darmstadt, N Yamanaka, et al. (2005) Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J 24 1093-1098.
120. A Le Monnier, E Carbonnelle, JR Zahar, et al. (2006) Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis 42 1135-1140.
121. Clinical and Laboratory Standard Institute (CLSI) (2002) Performance Standards for Antimicrobial Susceptibility Testing; 12th Informational Supplement. CLSI document M100-MS20. CLSI W, PA: Clinical and Laboratory Standard Institute
122. SJ Schrag, L McGee, CG Whitney, et al. (2004) Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob Agents Chemother 48 3016-3023.
123. AM Figueiredo, JD Connor, A Severin, et al. (1992) A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob Agents Chemother 36 886-889.
124. GA Jacoby (1994) Prevalence and resistance mechanisms of common bacterial respiratory pathogens. Clin Infect Dis 18 951-957.
125. TB Hyde, K Gay, DS Stephens, et al. (2001) Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286 1857-1862.
126. R Patel, MS Rouse, KE Piper and JM Steckelberg (1999) In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 34 119-122.
127. N Safdar, D Andes and WA Craig (2004) In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother 48 63-68.
128. GV Doern, AB Brueggemann, H Huynh and E Wingert (1999) Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997–98. Emerg Infect Dis 5 757-765.
129. CG Whitney, MM Farley, J Hadler, et al. (2000) Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343 1917-1924.
130. GV Doern, SS Richter, A Miller, et al. (2005) Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis 41 139-148.
131. Active Bacterial Core surveillance (ABCs) http://www.cdc.gov/abcs/index.html Accessed March 3, 2011
132. JA Finkelstein, SS Huang, J Daniel, et al. (2003) Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 112 862-869.
133. D Guillemot, E Varon, C Bernede, et al. (2005) Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 41 930-938.
134. J Hofmann, MS Cetron, MM Farley, et al. (1995) The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 333 481-486.
135. KE Arnold, RJ Leggiadro, RF Breiman, et al. (1996) Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr 128 757-764.
136. E Melander, K Ekdahl, G Jonsson and S Molstad (2000) Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 19 1172-1177.
137. SS Huang, VL Hinrichsen, AE Stevenson, et al. (2009) Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124 e1-11.
138. RE Gertz Jr, Z Li, FC Pimenta, et al. (2010) Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 201 770-775.
139. American Academy of Pediatrics, Subcommittee on Management of Acute Otitis Media (2004) Diagnosis and management of acute otitis media. Pediatrics 113 1451-1465.
140. K Seikel, S Shelton and GH McCracken Jr (1997) Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media. Pediatr Infect Dis J 16 710-711.
141. A Hoberman, JL Paradise, HE Rockette, et al. (2011) Treatment of acute otitis media in children under 2 years of age. N Engl J Med 364 105-115.
142. JS Bradley and JD Nelson (2010) Nelson's Pocket Book of Pediatric Antimicrobial Therapy. 18th ed Elk Grove Village, IL: American Academy of Pediatrics
143. SL Kaplan (2002) Management of pneumococcal meningitis. Pediatr Infect Dis J 21 589-591. discussion 613–614
144. IR Friedland, M Paris, S Ehrett, et al. (1993) Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 37 1630-1636.
145. H Peltola, I Roine, J Fernandez, et al. (2010) Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics 125 e1-e8.
146. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007:CD004405.
147. Brouwer MC, McIntyre P, de Gans J, et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010:CD004405.
148. PB McIntyre, CS Berkey, SM King, et al. (1997) Dexamethasone as adjunctive therapy in bacterial meningitis: a meta-analysis of randomized clinical trials since 1988. JAMA 278 925-931.
149. Bradley JS, Byington CL, Shah S, et al. The management of community-acquired pneumonia (CAP) in infants and children older than 3 months of age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA). Clin Infect Dis (In press).
150. M Arditi, EO Mason Jr, JS Bradley, et al. (1998) Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102 1087-1097.
151. J Ongkasuwan, TA Valdez, KG Hulten, et al. (2008) Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics 122 34-39.
152. RM Douglas, JC Paton, SJ Duncan and DJ Hansman (1983) Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 148 131-137.
153. S Black, H Shinefield, B Fireman, et al. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19 187-195.
154. B Fireman, SB Black, HR Shinefield, et al. (2003) Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22 10-16.
155. Centers for Disease Control and Prevention (2003) Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 52 739-740.
156. Centers for Disease Control and Prevention (2008) Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24–59 months who are not completely vaccinated. MMWR Morb Mortal Wkly Rep 57 343-344.
157. Centers for Disease Control and Prevetion (2010) National, state, and local area vaccination coverage among children aged 19–35 months – United States, 2009. MMWR Morb Mortal Wkly Rep 59 1171-1177.
158. BE Mahon, K Hsu, S Karumuri, et al. (2006) Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine 24 2514-2520.
159. D Goldblatt, J Southern, L Ashton, et al. (2006) Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 25 312-319.
160. RP Wise, J Iskander, RD Pratt, et al. (2004) Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA 292 1702-1710.
161. CG Grijalva, KA Poehling, JP Nuorti, et al. (2006) National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118 865-873.
162. SL Block, J Hedrick, CJ Harrison, et al. (2004) Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23 829-833.
163. KA Poehling, PG Szilagyi, CG Grijalva, et al. (2007) Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 119 707-715.
164. MH Kyaw, R Lynfield, W Schaffner, et al. (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 1455-1463.
165. Centers for Disease Control and Prevention (2009) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine – United States, 1997–2006. MMWR Morb Mortal Wkly Rep 58 1-4.
166. GJ Tyrrell, M Lovgren, N Chui, et al. (2009) Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine 27 3553-3560.
167. C Ardanuy, F Tubau, R Pallares, et al. (2009) Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997–2007. Clin Infect Dis 48 57-64.
168. HE Hsu, KA Shutt, MR Moore, et al. (2009) Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 360 244-256.
169. MR Jacobs, CE Good, S Bajaksouzian and AR Windau (2008) Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 47 1388-1395.
170. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae – Massachusetts, 2001–2006. MMWR Morb Mortal Wkly Rep 56 1077-1080.
171. C Techasaensiri, AF Messina, K Katz, et al. (2010) Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J 29 294-300.
172. J Benito-Fernandez, S Mintegi, I Pocheville-Gurutzeta, et al. (2010) Pneumococcal bacteremia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J 29 1142-1144.
173. Centers for Disease Control and Prevention (2009) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine – United States, 1997–2006. MMWR Morb Mortal Wkly Rep 58 1-4.
174. CJ Tsai, MR Griffin, JP Nuorti and CG Grijalva (2008) Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 46 1664-1672.
175. DJ Hendrickson, DA Blumberg, JP Joad, et al. (2008) Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 27 1030-1032.
176. Committee on Infectious Diseases, American Academy of Pediatrics (2010) Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics 126 186-190.
177. Centers for Disease Control and Prevention (2010) Prevention of pneumococcal disease among infants and children – use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 59(RR-11), 1-19.
178. Centers for Disease Control and Prevention (2010) Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine – United States, 2007. MMWR Morb Mortal Wkly Rep 59 253-257.
179. The National Institute of Child Health and Human Developments Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 325 73-80.
180. American Academy of Pediatrics (2009) Passive immunization. LK Pickering, CJ Baker, DW Kimberlin, SS Long,(Eds) Red Book: 2009 Report of the Committee on Infectious Diseases 28th ed Elk Grove Village, IL: American Academy of Pediatrics 55-67.
181. MH Gaston, JI Verter, G Woods, et al. (1986) Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med 314 1593-1599.
182. JM Falletta, GM Woods, JI Verter, et al. (1995) Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr 127 685-690.